NDA Partners, LLC
A Development Partner to the Pharmaceutical and Medical Device Industry
Value-Driven Program Execution
Principle III: Value-Driven Program Execution

All studies (in vitro, non-clinical, clinical, and CMC) must be designed to produce knowledge that directly impacts expected product value, as specified in the Target Product Profile, and data to support the labeled claims.

Home | About Us | Our Team | Development Principles | News and Events | Contact Us
© 2005-2011 NDA Partners LLC